Table 3 Comparison of clinical parameters between the training set and validation set of IgA patients and MN patients
IgA(n = 22) | MN(n = 46) | |||
|---|---|---|---|---|
Training set (n = 14) | Validation set (n = 8) | Training set (n = 37) | Validation set (n = 9) | |
Age (year) | 37.08 ± 9.27 | 42.88 ± 12.74 | 49.59 ± 12.48 | 49.00 ± 13.98 |
SBP (mmHg) | 127.38 ± 6.87 | 141.00 ± 27.24 | 131.83 ± 13.40 | 138.11 ± 20.10 |
DBP (mmHg) | 80.15 ± 6.62 | 87.00 ± 14.44 | 87.31 ± 11.92 | 91.56 ± 26.43 |
Hb (g/L) | 116.42 ± 19.44 | 129.94 ± 20.16 | 129.29 ± 17.47 | 132.87 ± 16.65 |
BUN (mmol/L) | 7.62 (4.00, 15.40) | 8.72 (3.60, 14.50) | 5.68 (3.20, 10.60) | 6.71 (2.30, 10.90) |
Cr (mmol/L) | 104.65 (53.00, 189.00) | 108.25 (53.00, 222.00) | 72.27 (36.00, 102.00) | 77.45 (36.00, 137.00) |
UA (mmol/L) | 351.89 (244.00, 624.00) | 366.42 (84.00, 538.00) | 336.54 ± 117.83 | 336.89 ± 96.42 |
eGFR (ml/min.1.75m2) | 70.93 ± 35.46 | 69.09 ± 33.54 | 93.47 ± 19.50 | 88.99 ± 29.48 |
Alb (g/L) | 36.45 (19.30, 44.10) | 33.87 (13.60, 43.8) | 24.78 ± 6.76 | 24.80 ± 6.42 |
TC (mmol/L) | 4.94 (2.61, 6.17) | 4.56 (3.24, 5.57) | 7.39 ± 2.19 | 6.97 ± 2.75 |
TG (mmol/L) | 1.54 (0.58, 4.85) | 1.60 (0.66, 3.40) | 2.90 ± 1.36 | 2.43 ± 1.33 |
HDL (mmol/L) | 1.29 (0.84, 2.70) | 1.41 (0.76, 2.86) | 1.49 ± 0.52 | 2.20 ± 1.26 |
LDL (mmol/L) | 3.21 ± 1.01 | 2.61 ± 0.59 | 5.14 ± 2.09 | 4.18 ± 2.16 |
Hematuria(%) | 11 (79%) | 8 (100%) | 22 (59%) | 2 (22%) |
Urinary protein quantitative (g/24 h) | 1.58 (0.67, 2.70) | 1.20 (0.75, 1.50) | 3.90 (2.44, 6.34) | 5.62 (4.00, 7.61) |
Renal longitudinal diameter (mm) | 103.77 ± 10.16 | 103.25 ± 10.79 | 108.62 ± 7.51 | 110.33 ± 14.00 |
Renal parenchyma thickness (mm) | 15.33 (10.00, 20.00) | 13.83 (12.00, 16.00) | 15.22 (12.00, 20.00) | 16.00 (13.00, 19.00) |